Audra Galang v. Sanofi S.A. et al
Consolidated
Lead case: 9:20-md-02924
Lead case: 9:20-md-02924
| Florida Southern District Court | |
| Judge: | Robin L Rosenberg |
| Case #: | 9:21-cv-81175 |
| Nature of Suit | 367 Torts - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability |
| Cause | 28:1446pl Petition for Removal - Product Liability |
| Case Filed: | Jul 02, 2021 |
| Terminated: | Jul 15, 2021 |
| Case in other court: | California Central, 2:21-cv-04869 |
| Last checked: Wednesday Dec 29, 2021 4:35 AM EST |
|
Defendant
Boehringer Ingelheim Pharmaceuticals, Inc.
|
Represented By
|
|
Defendant
Chattem Inc.
1715 West 38th Street
Chatanooga, TN 37409 |
Represented By
|
|
Defendant
Does
1 to 10 251 174th Street
Miami Beach, FL 33160 |
|
|
Defendant
GlaxoSmithKline LLC
|
Represented By
|
|
Defendant
Pfizer Inc
|
Represented By
|
|
Defendant
Sanofi S.A US Services Inc.
|
Represented By
|
|
Defendant
Sanofi S.A.
|
|
|
Defendant
Sanofi-Aventis U.S. LLC
|
Represented By
|
|
Plaintiff
Audra Galang
|
Represented By
|
| Docket last updated: 11 hours ago |
| Thursday, July 15, 2021 | ||
| 37 | 37
order
Administrative Order
Thu 07/15 4:12 PM
ORDER OF CONSOLIDATION AND ADMINISTRATIVE CLOSE-OUT. Signed by Judge Robin L. Rosenberg on 7/15/2021. See attached document for full details. (mc) |
|
| Tuesday, July 06, 2021 | ||
|
transfer
MDL Tag-Along/Transfer In Case Receipt
Tue 07/06 10:59 AM
MDL Transfer In Case Receipt from Central District of California. Case Number 2:21-cv-04869 with documents 1-33. Assigned FLSD Case Number 9:21-cv-81175-RLR Audra Galang v. Sanofi S.A. et al on 7/2/2021. Re: FLSD MDL Case Number 9:20-md-02924-RLR. Clerks Note: JPML notified (mc) |
||
| Friday, July 02, 2021 | ||
| 35 | 35 Clerks Notice of Judge Assignment to Judge Robin L. Rosenberg. (mc) | |
| 34 | 34
transfer
Case Transferred In - District Transfer - CV - NO FEE
Fri 07/02 3:30 PM
Case transferred in from California Central; Case Number 2:21-cv-04869. Electronic file including transfer order and docket sheet received. .(mc). |
|
| Thursday, July 01, 2021 | ||
| 33 | 33
order
MDL Conditional Transfer Order
Fri 07/02 11:57 AM
Conditional Transfer Order - 67 from the United States Judicial Panel on Multidistrict Litigation, MDL 2924, transferring case to USDC, Southern District of Florida and assigned to Honorable Robin L. Rosenberg. Case transferred electronically. (MD JS-6. Case Terminated.) (iv) |
|
| Wednesday, June 30, 2021 | ||
| 32 | 32
SUPPLEMENT to Stipulation Extending Time to Answer (30 days or less),11 filed by Defendant GlaxoSmithKline, LLC.(Tam, Jonathan)
|
|
|
Att: 1
Proposed Order
|
||
| Tuesday, June 29, 2021 | ||
| 31 | 31
RESPONSE filed by Plaintiff Audra Galang to Order to Show Cause (Toveg, Isaac)
|
|
| 30 | 30
RESPONSE filed by Defendants Boehringer Ingelheim Pharmaceuticals, Inc., Chattem Inc., Pfizer Inc., Sanofi S.A US Services Inc., Sanofi-Aventis U.S. LLCto Order to Show Cause,12 (Trotter, Rhonda)
|
|
| 29 | 29
CORPORATE DISCLOSURE STATEMENT filed by Defendant Boehringer Ingelheim Pharmaceuticals, Inc. identifying Boehringer Ingelheim USA Corporation and Boehringer Ingelheim Corporation, both privately owned corporations as Corporate Parent. (Blaschke, Matthew)
|
|
| 28 | 28
NOTICE of Interested Parties filed by Defendant Boehringer Ingelheim Pharmaceuticals, Inc., identifying Boehringer Ingelheim USA Corporation and Boehringer Ingelheim Corporation, both privately held corporations. (Blaschke, Matthew)
|
|
| 27 | 27
RESPONSE filed by Defendant GlaxoSmithKline, LLC Response to Order to Show Cause (Tam, Jonathan)
|
|
| 26 | 26
DECLARATION of Matthew J. Blaschke Declaration of Lead Trial Counsel filed by Defendant Boehringer Ingelheim Pharmaceuticals, Inc.. (Blaschke, Matthew)
|
|
| 25 | 25
NOTICE of Appearance filed by attorney Matthew James Blaschke on behalf of Defendant Boehringer Ingelheim Pharmaceuticals, Inc. (Attorney Matthew James Blaschke added to party Boehringer Ingelheim Pharmaceuticals, Inc.(pty:dft))(Blaschke, Matthew)
|
|
| 24 | 24
DECLARATION of Jessica B. Rydstrom Lead Trial Counsel for Defendant Pfizer Inc. filed by Defendant Pfizer Inc.. (Rydstrom, Jessica)
|
|
| 23 | 23
CERTIFICATE of Interested Parties filed by Defendant Pfizer Inc., (Rydstrom, Jessica)
|
|
| 22 | 22
NOTICE of Appearance filed by attorney Jessica Bodger Rydstrom on behalf of Defendant Pfizer Inc. (Attorney Jessica Bodger Rydstrom added to party Pfizer Inc.(pty:dft))(Rydstrom, Jessica)
|
|
| Monday, June 28, 2021 | ||
| 21 | 21
DECLARATION of Rhonda R. Trotter filed by Defendants Chattem Inc., Sanofi S.A US Services Inc., Sanofi-Aventis U.S. LLC. (Trotter, Rhonda)
|
|
| 20 | 20
CERTIFICATE of Interested Parties filed by Defendant Chattem Inc., identifying Sanofi. (Trotter, Rhonda)
|
|
| 19 | 19
CERTIFICATE of Interested Parties filed by Sanofi US Services Inc. Sanofi S.A US Services Inc., identifying Sanofi. (Trotter, Rhonda)
|
|
| 18 | 18
CERTIFICATE of Interested Parties filed by Sanofi-Aventis U.S. LLC Sanofi-Aventis U.S. LLC, identifying Sanofi. (Trotter, Rhonda)
|
|
| 17 | 17
DECLARATION of Isaac Toveg Lead counsel for Plaintiff Audra Galang filed by Plaintiff Audra Galang. (Toveg, Isaac)
|
|
| 16 | 16
NOTICE of Appearance filed by attorney Tommy Huynh on behalf of Defendants Chattem Inc., Sanofi S.A US Services Inc., Sanofi-Aventis U.S. LLC (Attorney Tommy Huynh added to party Chattem Inc.(pty:dft), Attorney Tommy Huynh added to party Sanofi S.A US Services Inc.(pty:dft), Attorney Tommy Huynh added to party Sanofi-Aventis U.S. LLC(pty:dft))(Huynh, Tommy)
|
|
| 15 | 15
NOTICE of Appearance filed by attorney Rhonda R Trotter on behalf of Defendants Chattem Inc., Sanofi S.A US Services Inc., Sanofi-Aventis U.S. LLC (Attorney Rhonda R Trotter added to party Chattem Inc.(pty:dft), Attorney Rhonda R Trotter added to party Sanofi S.A US Services Inc.(pty:dft), Attorney Rhonda R Trotter added to party Sanofi-Aventis U.S. LLC(pty:dft))(Trotter, Rhonda)
|
|
| 14 | 14
NOTICE of Appearance filed by attorney Jonathan S Tam on behalf of Defendant GlaxoSmithKline, LLC (Tam, Jonathan)
|
|
| Friday, June 25, 2021 | ||
| 13 | 13
DECLARATION of Jonathan Tam Declaration of Lead Trial Counsel filed by Defendant GlaxoSmithKline, LLC. (Tam, Jonathan)
|
|
| 12 | 12
MINUTES (IN CHAMBERS) ORDER TO SHOW CAUSE RE: STANDING ORDER by Judge John F. Walter. Counsel are ordered to show cause in writing by June 29, 2021 why the Court should not impose sanctions in the amount of $750.00 for violating the Court's Standing Order. (iv)
|
|
| Tuesday, June 22, 2021 | ||
| 11 | 11
STIPULATION Extending Time to Answer the complaint as to GlaxoSmithKline, LLC answer now due 7/7/2021; Boehringer Ingelheim Pharmaceuticals, Inc. answer now due 7/7/2021; Chattem Inc. answer now due 7/7/2021; Pfizer Inc. answer now due 7/7/2021; Sanofi S.A US Services Inc. answer now due 7/7/2021; Sanofi S.A. answer now due 7/7/2021, re Notice of Removal (Attorney Civil Case Opening),1 filed by defendant GlaxoSmithKline, LLC.(Tam, Jonathan)
|
|
| Thursday, June 17, 2021 | ||
| 10 | 10
MINUTE ORDER IN CHAMBERS by Judge John F. Walter. Counsel are hereby notified that a Scheduling Conference has been set for July 19, 2021 at 1:15 p.m. before Judge John F. Walter in Courtroom 7A, 350 W. 1st St, Los Angeles, CA 90012. Lead Trial Counsel shall attend all proceedings before this Court, including the Scheduling Conference. Counsel are directed to comply with Rule 26 of the Federal Rules of Civil Procedure and Local Rule 26-1 in a timely fashion and to file a Joint Report, on or before July 6, 2021. (et)
|
|
| 9 | 9
STANDING ORDER by Judge John F. Walter. READ THIS ORDER CAREFULLY. IT CONTROLS THE CASE AND DIFFERS IN SOME RESPECTS FROM THE LOCAL RULES. This action has been assigned to the calendar of Judge John F. Walter. (et)
|
|
| 8 | 8 TEXT ONLY ENTRY ORDER DISMISSING DOES: Pursuant to Local Rule 19-1, no complaint or petition shall be filed that includes more than ten Doe or fictitiously named parties. Accordingly, the Court hereby dismisses the action as to Doe Defendants 11 through 100, inclusive.THERE IS NO PDF DOCUMENT ASSOCIATED WITH THIS ENTRY. (sr) TEXT ONLY ENTRY | |
| Wednesday, June 16, 2021 | ||
| 7 | 7
NOTICE of Interested Parties filed by defendant GlaxoSmithKline, LLC, identifying GlaxoSmithKline plc. (Tam, Jonathan)
|
|
| 6 | 6
NOTICE OF DEFICIENCIES in Attorney Case Opening. The following error(s) was found: No Notice of Interested Parties has been filed. A Notice of Interested Parties must be filed with every partys first appearance. See Local Rule 7.1-1. Counsel must file a Notice of Interested Parties immediately. Failure to do so may be addressed by judicial action, including sanctions. See Local Rule 83-7. (lh)
|
|
| 5 | 5
NOTICE TO PARTIES OF COURT-DIRECTED ADR PROGRAM filed. (lh)
|
|
| 4 | 4
NOTICE OF ASSIGNMENT to District Judge John F. Walter and Magistrate Judge Jean P. Rosenbluth. (lh)
|
|
| Tuesday, June 15, 2021 | ||
| 3 | 3
PROOF OF SERVICE filed by defendant Glaxosmithkline LLC, re Notice of Removal (Attorney Civil Case Opening),1 served on 6/15/2021. (Tam, Jonathan)
|
|
| 2 | 2
CIVIL COVER SHEET filed by Defendant Glaxosmithkline LLC. (Tam, Jonathan)
|
|
| 1 | 1
NOTICE OF REMOVAL from Los Angeles County Superior Court, case number 21STCV19417 Receipt No: ACACDC-31470696 - Fee: $402, filed by defendant Glaxosmithkline LLC. (Attorney Jonathan S Tam added to party Glaxosmithkline LLC(pty:dft))(Tam, Jonathan)
|
|
|
Att: 1
State Court Complaint
|
||
| NON-CONFORMED FILED COPY OF COMPLAINT against Defendants Boehringer Ingelheim Pharmaceuticals, Inc., Chattem Inc., Does, GlaxoSmithKline, LLC, Pfizer Inc., Sanofi S.A US Services Inc., Sanofi S.A., Sanofi-Aventis U.S. LLC., filed by Plaintiff Audra Galang. (SUBMITTED ATTACHED TO NOTICE OF REMOVAL1 ) (lh) | ||